분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2010-11-25 12:47:13 , Hit : 3385
 Vertex submits application for hepatitis C drug


November 23, 2010 07:50 AM E-mail| |Comments (0)| Text size – +  E-mail this article  To: Invalid email address Add a personal message:  Your e-mail: Invalid email address  
Sending your articleYour article has been sent. Globe Staff

Vertex Pharmaceuticals Inc. said today that it has completed the submission of a New Drug Application that seeks regulatory approval for telaprevir, a hepatitis C drug candidate with the potential to generate billions of dollars in annual revenue.

The submission includes a request to the US Food and Drug Administration to reduce the FDA’s review time from 10 months to six months, Cambridge-based Vertex said in a press release.

The release included a statement Matthew Emmens, the company's chairman, president, and chief executive.

“This submission is a milestone in our more than 15-year effort to change the way hepatitis C is treated,” Emmens said. “We are committed to working closely with the FDA to make telaprevir available as quickly as possible to the millions of people with hepatitis C who need new medicines to increase their chances for a viral cure.”

A recent Globe story noted that Vertex was on the verge of moving forward on telaprevir. One challenge: Global drug giant Merck & Co. is developing its own hepatits C drug candidate that could compete with telaprevir for the same market.









967   Strides Against Hepatitis C Open Door to Blockbusters  이성욱 2010/11/02 2519
966   Black patients fare well on Vertex hepatitis C drug  이성욱 2010/11/02 2655
965   NC State Develops More Precise Genetic ‘Off Switches’  이성욱 2010/11/03 2591
964   Breakthrough in cancer vaccine research  이성욱 2010/11/08 2632
963   DNA sequence may be lost in translation  이성욱 2010/11/10 2738
962   Lung Cancer in Smokers, Nonsmokers May Be a Different Disease  이성욱 2010/11/10 2539
961   Why brain tumors hard to treat  이성욱 2010/11/23 2879
  Vertex submits application for hepatitis C drug  이성욱 2010/11/25 3385
959   Tumours grow their own blood vessels  이성욱 2010/11/25 2307
958   Top 5 papers of 2010  이성욱 2010/12/10 2288
957   Microbe gets toxic response  이성욱 2010/12/10 2423
956   Basel Declaration defends animal research  이성욱 2010/12/10 2315
955   Missing Molecules Hold Promise of Therapy for Pancreatic Cancer: Lost microRNAs Put Brakes on Tumors  이성욱 2010/12/22 2210
954   HIV patient with leukemia treated through stem cell transplant  이성욱 2010/12/23 4967
953   Top 5 papers of 2010  이성욱 2010/12/28 2549
952   Smoking May Worsen Pain For Cancer Patients  이성욱 2010/12/28 2654
951   key interaction in hepatitis C virus  이성욱 2010/12/30 2207
950   Parallels Between Cancers, Infection Suppression: Same Proteins Involved, but Cancer Takes Hold When Response Gets out of Control  이성욱 2011/01/11 2566
949   Cancer Can Develop in Catastrophic Burst  이성욱 2011/01/13 2809
948   Viral Evasion Gene Reveals New Targets for Eliminating Chronic Infections  이성욱 2011/01/17 2298

[이전 10개] [1]..[11][12][13][14][15] 16 [17][18][19][20]..[64] [다음 10개]
 

Copyright 1999-2021 Zeroboard / skin by ROBIN